Valuation
- Market cap
- 0
- Revenue TTM
- $0
- Net income TTM
- $-60,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 100
- Avg volume
- —
- Day's range
- $0.00 – $0.00
- Shares out
- —
- Stochastic %K
- —
- Beta
- -0.33
- Analysts
- —
- Price target
- —
Company profile
ZIM Corporation operates in the biomedical and emerging technology companies. It focuses on developing intellectual property, and research and development in the areas of new synthetic drugs and Immunotherapies. The company also offers spherical metal powders for additive manufacturing; and develops novel biomaterial for regenerative medicine. ZIM Corporation was founded in 1997 and is headquartered in Ottawa, Canada...
Show more
ZIM Corporation operates in the biomedical and emerging technology companies. It focuses on developing intellectual property, and research and development in the areas of new synthetic drugs and Immunotherapies. The company also offers spherical metal powders for additive manufacturing; and develops novel biomaterial for regenerative medicine. ZIM Corporation was founded in 1997 and is headquartered in Ottawa, Canada.
- Industry
- Biotechnology
- Sector
- Healthcare
- Website
- https://zim.biz
- Address
- 150 Isabella Street, Suite 150, Ottawa, Canada
Latest news
No headlines yet.
